Shuji Kubo

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 13, 2026
Mesenchymal stem cell-mediated delivery boosts the efficacy of suicide gene therapy based on retroviral replicating vectors in peritoneally disseminated cancer.

|Nov 27, 2024
Human-Brain-Derived Ischemia-Induced Stem Cell Transplantation Is Associated with a Greater Neurological Functional Improvement Compared with Human-Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in Mice After Stroke.

Shuichi Tanada, Takayuki Nakagomi, Akiko Nakano-Doi

|Jun 19, 2024
Administration of Human-Derived Mesenchymal Stem Cells Activates Locally Stimulated Endogenous Neural Progenitors and Reduces Neurological Dysfunction in Mice after Ischemic Stroke.

Shuichi Fujiwara, Akiko Nakano-Doi, Toshinori Sawano

|Mar 13, 2024
Targeted Suicide Gene Therapy with Retroviral Replicating Vectors for Experimental Canine Cancers.

Emiko Sonoda-Fukuda, Yuya Takeuchi, Nao Ogawa

|Oct 14, 2023
Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model.

Hiroaki Fujino, Emiko Sonoda-Fukuda, Lisa Isoda

|Aug 26, 2023
Microglia Negatively Regulate the Proliferation and Neuronal Differentiation of Neural Stem/Progenitor Cells Isolated from Poststroke Mouse Brains.

Yoshinobu Hirano, Takayuki Nakagomi, Akiko Nakano-Doi

Pageof 2

Frequent Collaborators

3 joint publications

Takayuki Nakagomi

3 joint publications

Toshinori Sawano

3 joint publications

Noriyuki Kasahara

2 joint publications

Toru Takarada